Arcturus Bioscience
Founded Year
1996Stage
Acquired | AcquiredTotal Raised
$55MAbout Arcturus Bioscience
Provider of laser capture microdissection (LCM) instruments and reagents for the analysis of microscopic tissue samples. The company provides tools that enable researchers to perform cell-based analysis of disease progression utilizing small and pure samples. The company has developed this technology platform for genetic analysis of biopsy samples and has applied its platform to discover cell-specific gene signatures associated with human diseases such as cancer.
Missing: Arcturus Bioscience's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Arcturus Bioscience's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Arcturus Bioscience Frequently Asked Questions (FAQ)
When was Arcturus Bioscience founded?
Arcturus Bioscience was founded in 1996.
Where is Arcturus Bioscience's headquarters?
Arcturus Bioscience's headquarters is located at 400 Logue Avenue, Mountain View.
What is Arcturus Bioscience's latest funding round?
Arcturus Bioscience's latest funding round is Acquired.
How much did Arcturus Bioscience raise?
Arcturus Bioscience raised a total of $55M.
Who are the investors of Arcturus Bioscience?
Investors of Arcturus Bioscience include Agendia, Dynafund Ventures, ITIC Ventures, Incubic Venture Capital, ABS Capital Partners and 6 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.